This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Hated Stocks to Buy to Beat the S&P in 2013


Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Up first is health care IT firm Cerner (CERN - Get Report). Cerner's business centers around harnessing the tailwinds from the transition to digital medical records -- and the firm has been one of the industry's biggest names. Today, almost a third of U.S. hospitals use Cerner's Millennium platform to store everything from medical data to financial records. It's not just hospitals either; pharmacies and physician offices are using Cerner's platform to manage their records too.

>>5 Health Care Stocks Ready to Break Out

But none of that has stopped investors from hating this stock. At last count, Cerner's short interest ratio of 12.9 means that it would take short sellers two and a half weeks of buying activity to cover their positions at current volume levels. That's a lot of buying.

There are some big incentives working in Cerner's favor right now; the biggest is legislation. Government rules have mandated that medical facilities use electronic medical records for a while now, and because Cerner's platform fulfills the legal requirements of the program, it's enjoyed significant market share.

Another big incentive for medical facilities is getting paid. Cerner's offerings cut down the administrative steps needed to get practices and hospitals payments from either insurance companies or government programs. That helps lessen the blow of a costly medical IT package.

A push to attract smaller medical offices with a less pricey suite of tools should help round out Cerner's client list in 2013. In the meantime, the firm's $1.3 billion of net balance sheet cash should be plenty of wherewithal to handle any unexpected bumps in the road.
2 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
CERN $56.16 -2.60%
CMG $420.87 -0.60%
DLR $88.01 -0.02%
EQIX $330.49 0.69%
MCO $95.74 -3.40%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs